How I Manage Hypertension and Proteinuria Associated with VEGF Inhibitor

Clin J Am Soc Nephrol. 2023 Jan 1;18(1):121-123. doi: 10.2215/CJN.05610522. Epub 2022 Aug 17.

Authors

Arash Rashidi¹, Rimda Wanchoo², Hassan Izzedine³

Affiliations

¹ Division of Nephrology & Hypertension, University Hospitals Cleveland Medical Center, Cleveland, Ohio.
² Division of Kidney Diseases and Hypertension, The Glomerular Center at Northwell, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York.
³ Department of Nephrology, Peupliers Private Hospital, Ramsay Générale de Santé, Paris, France.

No abstract available

MeSH terms

Angiogenesis Inhibitors / adverse effects
Humans
Hypertension* / drug therapy
Proteinuria / chemically induced
Proteinuria / drug therapy
Vascular Endothelial Growth Factor A* / therapeutic use

Substances

Vascular Endothelial Growth Factor A
Angiogenesis Inhibitors